Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04266938 · ClinicalTrials.gov registry record · NA
Impact of Rapid ART Initiation on Retention in Care in the Southern US
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
NCT04266938 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 258 participants.
The verdict
NCT04266938, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
Study Summary
Impact of Rapid ART Initiation on Retention in Care in the Southern US Specific Goals and Aims: The major goal for this study is to determine if rapid start of antiretroviral (ART) therapy increases retention in HIV medical care. The investigators hypothesize that there will be an increase in retention in care with rapid start, by removing barriers that would normally delay enrollment in a treatment program and enforce the importance of linkage to care and ART initiation from diagnosis. In order to test this hypothesis, the investigators have the following specific aims for their proposed study: 1. Study retention in care after rapid ART start in comparison to standard of care. 2. Analyze risk factors for decreased retention in care, with focus on high-risk populations. 3. Analyze potential demographic and geographic determinants of retention in care. 4. Generate retention in care data in a Southern US state. The investigators hypothesize the introduction of rapid start ART, as well as the introduction of care navigators, will lead to improved clinical outcomes, including retention in care at one year, viral suppression at one year, time to viral suppression, and time to first missed appointment. In the event rapid start ART fails to have a positive impact on clinical outcomes, the results of this study will still positively contribute to the knowledge gap, since there is a scarcity of data in the Southern United States, specifically in high-risk populations, such as racial and ethnic minorities, youth, and patients co-infected with hepatitis C.
Interventions
- BEHAVIORAL Rapid start of antiretrovirals
- BEHAVIORAL Retrospective analysis
- BEHAVIORAL Non- RAPID start
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2024-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04266938
The ClinicalTrials.gov registry entry for NCT04266938 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rapid start of antiretrovirals is the first listed.
NCT04266938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04266938 about?
NCT04266938 is a clinical study titled "Impact of Rapid ART Initiation on Retention in Care in the Southern US". Impact of Rapid ART Initiation on Retention in Care in the Southern US Specific Goals and Aims: The major goal for this study is to determine if rapid start of antiretroviral (ART) therapy increases retention in HIV medical care. The investigators hypothesize that there will be an increase in rete...
What is the current status of trial NCT04266938?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2021-06-01. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT04266938?
The interventions under investigation include: Rapid start of antiretrovirals (BEHAVIORAL), Retrospective analysis (BEHAVIORAL), Non- RAPID start (BEHAVIORAL).
Who is sponsoring clinical trial NCT04266938?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.